< Back to latest news & events

Knowledge Hub

Still confident the UPC could open in December 2017

March 2017

Last week the UPC Preparatory Committee announced it was “confident” that the provisional application phase of the UPC could start at the end of May 2017. This timing would enable the Court to make necessary preparations before the planned entry into force in December 2017.

One caveat was that …”The timetable of the entry into force is subject to change given the reliance on national governments to accede to the Protocol on Provisional Application however regular updates will appear on this website on progress.”

The different national governments are at different stages of readiness; 14 member states have signed to date. The UK signed the Protocol on Provisional Application on 14 December 2016, however a Statutory Instrument to give the Protocol legal effect in the UK is still awaited.

Other UK preparations for the UPC are in good shape; the main implementing legislation was complete last year (Patents Order 2016 No 388) and earlier this month the “Patents (Isle of Man) (Amendment) Order 2017” was published, (the Order gives effect to UP and UPC by making equivalent provision for the Isle of Man to that which are made for the UK by the Patents Order 2016 No 388).

Ratification of the UPC Agreement (UPCA) in the UK was hoped to happen before the UK triggered Article 50. This seems unlikely now, given that it was announced that on the 29th March, British PM Theresa May will trigger Article 50, in which the UK’s decision to leave the European Union formally begins. Without the Statutory Instrument to give the Protocol legal effect in the UK, some pieces in the UK ratification puzzle are still missing.

We will have to wait and see how quickly these final pieces can be slotted into place, before we know when the UK will formally ratify the UPCA.

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article